On January 9, 2026, the Hong Kong stock market opened with mixed performance. The Hang Seng Index rose by 0.47%, the Hang Seng China Enterprises Index increased by 0.35%, the Hang Seng Tech Index climbed by 0.38%, and the Hang Seng China-Affiliated Corporations Index went up by 0.45%.

In terms of sectors, the Hong Kong internet medical sector showed notable gains. JD HEALTH rose by 1.29%, ALI HEALTH increased by 2.00%, and PA GOODDOCTOR went up by 1.09%. The Hong Kong electrical equipment sector also performed well, with GOLDWIND rising by 4.22% and JLMAG increasing by 2.30%. The Hong Kong biotechnology sector experienced a decline, with GENFLEET-B falling by 4.52%.

TENCENT remained flat at 0.00%. The company repurchased approximately 1.034 million shares on January 8, 2026, at a price range of HKD 610.5 to HKD 618.5 per share, spending around HKD 636 million. This move indicates the company's active efforts to enhance shareholder value.

MINIMAX-WP surged by 42.67%. The company is set to be listed on the Hong Kong Stock Exchange on January 9, 2026. In pre-market trading, its stock price increased by 14% to 19% compared to the offering price, reflecting strong market interest in this leading AI model company.

JINXUN RESOURCE rose by 26.67%. The company, focused on copper resource development and new energy materials, will be listed on the Hong Kong Stock Exchange on January 9, 2026. In pre-market trading, its stock price increased by 25% to 40%, showing significant investor interest. The company’s global offering was oversubscribed by 143.46 times, with an offering price of HKD 30 per share.

RIBOLIFE-B increased by 29.38%. The company announced a global offering of 31.61 million H shares at an issue price of HKD 57.97 per share, raising approximately HKD 1.702 billion. The Hong Kong public offering was oversubscribed by 101.06 times, and the international offering was oversubscribed by 16.7 times. The shares are expected to be listed on the Hong Kong Stock Exchange on January 9, 2026.

MINIEYE fell by 0.77%. The company repurchased 3.0048 million H shares from January 7 to 8, 2026, spending approximately HKD 44.8786 million. The board stated that the repurchase reflects confidence in the company's long-term value and helps enhance market value and shareholder returns.